The present study was designed to determine the pattern of the expressions of miR-340, LGR5, and FOXO1 genes in ovarian cancer tissue samples as well as their association with drug resistance in ovarian cancer cell lines. This evidence concerns the gene FOXO1 and ovarian carcinoma.